본문으로 건너뛰기
← 뒤로

Anaplastic thyroid carcinoma with osteoclast-like giant cells: a case report and a study of a potential therapeutic approach.

증례보고 1/5 보강
Medical molecular morphology 2026 Vol.59(1) p. 64-70 OA
Retraction 확인
출처

Yukino K, Komohara Y, Zhao S, Yamada R, Fujiwara Y, Murakami A

📝 환자 설명용 한 줄

Anaplastic thyroid carcinoma (ATC) is a highly aggressive neoplasm with no effective treatment options.

이 논문을 인용하기

↓ .bib ↓ .ris
APA Yukino K, Komohara Y, et al. (2026). Anaplastic thyroid carcinoma with osteoclast-like giant cells: a case report and a study of a potential therapeutic approach.. Medical molecular morphology, 59(1), 64-70. https://doi.org/10.1007/s00795-025-00443-1
MLA Yukino K, et al.. "Anaplastic thyroid carcinoma with osteoclast-like giant cells: a case report and a study of a potential therapeutic approach.." Medical molecular morphology, vol. 59, no. 1, 2026, pp. 64-70.
PMID 40705032 ↗

Abstract

Anaplastic thyroid carcinoma (ATC) is a highly aggressive neoplasm with no effective treatment options. ATC with osteoclast-like giant cells (OGCs; ATC/OGC) is a rare variant of ATC, and no detailed pathological examination has been reported to date. A 59-year-old woman presented with sudden neck swelling. Computed tomography revealed a 5 cm tumor in the thyroid gland, which was surgically resected. Pathological examination revealed a diagnosis of ATC/OGC. The patient succumbed to progressive lung metastases within four months despite postoperative lenvatinib therapy. Immunohistochemical (IHC) examination indicated absence of PD-L1 expression in the OGCs, which comprised the majority of the tumor, with only sparse T cell infiltration in the area occupied by OGCs. Increased TGF-β expression was observed in the area containing OGCs, and both OGCs and infiltrating myeloid cells, including CD1a/CD11c-positive dendritic cells and CD68/CD163/CD204-positive macrophages, appeared to produce TGF-β. Pathological analysis of this case suggests that OGCs might be involved in immune suppression by secreting TGF-β, potentially serving as a critical cytokine in the immunosuppressive microenvironment of ATC/OGC. TGF-β-targeted therapy might be useful in the treatment of this very rare subtype of ATC.

🏷️ 키워드 / MeSH 📖 같은 키워드 OA만

🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반

🟢 PMC 전문 열기